1. A phase 2 study of dalantercept, an activin receptor‐like kinase‐1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Issue 23 (20th September 2016) Authors: Jimeno, Antonio; Posner, Marshall R.; Wirth, Lori J.; Saba, Nabil F.; Cohen, Roger B.; Popa, Elizabeta C.; Argiris, Athanassios; Grossmann, Kenneth F.; Sukari, Ammar; Wilson, Dawn; Zhang, Xiaosha; Sun, Jade; Glasser, Chad; Attie, Kenneth M.; Sherman, Matthew L.; Pandya, Susan S.; Weiss, Jared Journal: Cancer Issue: Volume 122:Issue 23(2016) Page Start: 3641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗